Steven Cohen's KYMR Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 173,147 shares of Kymera Therapeutics, Inc. (KYMR) worth $13.47 M, representing 0.02% of the portfolio. First purchased in 2021-Q2, this medium-term investment has been held for 10 quarters.
Based on 13F filings, Steven Cohen has maintained a strategic position in KYMR, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2022, adding 594,600 shares. Largest reduction occurred in Q2 2022, reducing 652,800 shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's Kymera Therapeutics (KYMR) Holding Value Over Time
Track share changes against reported price movement
Quarterly Kymera Therapeutics (KYMR) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | -753 | Reduce 0.43% | 173,147 | $77.81 |
| Q3 2025 | -10,578 | Reduce 5.73% | 173,900 | $56.60 |
| Q2 2025 | +184,478 | New Buy | 184,478 | $43.64 |
| Q4 2023 | -81,400 | Sold Out | 0 | $0.00 |
| Q3 2023 | +81,400 | New Buy | 81,400 | $13.90 |
| Q2 2022 | -652,800 | Sold Out | 0 | $0.00 |
| Q1 2022 | +594,600 | Add 1021.65% | 652,800 | $42.32 |
| Q4 2021 | -99,200 | Reduce 63.02% | 58,200 | $63.49 |
| Q3 2021 | +89,800 | Add 132.84% | 157,400 | $58.74 |
| Q2 2021 | +67,600 | New Buy | 67,600 | $48.51 |
Steven Cohen's Kymera Therapeutics Investment FAQs
Steven Cohen first purchased Kymera Therapeutics, Inc. (KYMR) in Q2 2021, acquiring 67,600 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held Kymera Therapeutics, Inc. (KYMR) for 10 quarters since Q2 2021.
Steven Cohen's largest addition to Kymera Therapeutics, Inc. (KYMR) was in Q1 2022, adding 652,800 shares worth $27.63 M.
According to the latest 13F filing for Q4 2025, Steven Cohen's firm, Point72 Asset Management, L.P., owns 173,147 shares of Kymera Therapeutics, Inc. (KYMR), valued at approximately $13.47 M.
As of the Q4 2025 filing, Kymera Therapeutics, Inc. (KYMR) represents approximately 0.02% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in Kymera Therapeutics, Inc. (KYMR) was 652,800 shares, as reported at the end of Q1 2022.